Type of Deal Value Acquirer Target Adviser to acquirer (tax) Adviser to target (tax) Acquisition $2.18 billion Darling International Vion Ingredients K&L Gates / Clifford Chance Acquisition $1.6 billion Pacific Rubiales Energy Petrominerales Norton Rose Fulbright McCarthy Tetrault / Torys Acquisition $1.13 billion Aspen GSK (thrombosis drug brands) Bredin Prat - Julien Gayral / Slaughter & May Merger $1.1 billion Industrial Developments International Verde Realty Operating Partnership Weil, Gotshal & Manges - Scott Sontag Acquisition $1.05 billion Vista Equity Partners Active Network Kirkland & Ellis DLA Piper Acquisition $930 million Monsanto Company Climate Corporation Latham & Watkins Wilson Sonsini Goodrich & Rosati Acquisition $453 million Ultrapar Participações Imifarma Produtos Farmacêuticos e Cosméticos Lefosse Advogados Acquisition $280 million Hochschild Mining International Minerals Stikeman Elliott - Dean Kraus, John O’Connor Acquisition Undisclosed AXA Liabilities Managers Global Reinsurance Stikeman Elliott Acquisition Undisclosed GPVTL Canada Xtreme Labs Stikeman Elliott Type of Deal Value Issuer/Borrower Lead managers/arrangers Adviser to issuer/borrower (tax) Adviser to lead managers (tax) Senior Notes Offering $4.5 billion General Motors Company Citigroup Jenner & Block Davis Polk & Wardwell - Samuel Dimon Convertible Bonds Issue $641.4 million CapitaLand Credit Suisse Allen & Overy / Allen & Gledhill Linklaters / WongPartnership Senior Notes Offering $500 million Marsh & McLennan Companies Goldman Sachs / HSBC / Merrill Lynch / Deutsche Bank Davis Polk & Wardwell - Lucy Farr Willkie Farr & Gallagher Initial Public Offering $192.3 million Ophthotech Corporation Morgan Stanley / JP Morgan Wilmer Cutler Pickering Hale and Dorr Davis Polk & Wardwell
October 06 2013